OptimizeRx Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
25.40
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
4
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.04
|
0.07
|
0.03
|
75.00%
|
|
2022-06-30
|
0.09
|
0.04
|
-0.05
|
-55.56%
|
|
2022-03-31
|
-0.01
|
-0.01
|
0.00
|
0.00%
|
|
2021-12-31
|
0.21
|
0.22
|
0.01
|
4.76%
|
|
2021-09-30
|
0.13
|
0.09
|
-0.04
|
-30.77%
|
|
2021-06-30
|
0.07
|
0.10
|
0.03
|
42.86%
|
|
2021-03-31
|
0.01
|
0.03
|
0.02
|
200.00%
|
|
2020-12-31
|
0.16
|
0.16
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.10
|
|
2021-12-31
|
0.44
|
|
2020-12-31
|
0.19
|
|
2019-12-31
|
0.07
|
|
2018-12-31
|
0.00
|
|
2017-12-31
|
-0.16
|
|
2016-12-31
|
-0.11
|
|
2015-12-31
|
-0.02
|
|
2014-12-31
|
-0.14
|
|
2013-12-31
|
0.00
|
|
2012-12-31
|
-0.03
|
|
2011-12-31
|
-0.46
|
|
2010-12-31
|
-0.46
|
|
2009-12-31
|
-1.08
|
|
2008-12-31
|
-159.23
|